The present study has also demonstrated that the serum levels of MMP-9 and TIMP-1 were significantly higher in the endometrial cancer group than in the healthy control group, and serum MMP-9 was elevated according to the depth of myometrial invasion and lymph-vascular space involvement. The gene discussed is MMP9; the disease is endometrial cancer.